OKYO Pharma Limited (NASDAQ:OKYO) Sees Significant Drop in Short Interest

OKYO Pharma Limited (NASDAQ:OKYO) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 217,900 shares, a decline of 35.5% from the February 28th total of 338,000 shares. Based on an average daily volume of 178,700 shares, the short-interest ratio is presently 1.2 days. Currently, 0.9% of the shares of the company are sold short.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of OKYO Pharma in a research report on Tuesday, February 18th.

OKYO Pharma Price Performance

Shares of OKYO Pharma stock traded down $0.08 on Friday, hitting $1.35. The company’s stock had a trading volume of 44,082 shares, compared to its average volume of 114,402. OKYO Pharma has a 1 year low of $0.81 and a 1 year high of $1.74. The firm has a fifty day moving average price of $1.21 and a 200-day moving average price of $1.12.

About OKYO Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.